Shares in Endo Pharmaceuticals (NSDQ:ENDP ) have risen nearly 20% so far today after the medical giant beat expectations on Wall Street with its second quarter results.
The Dublin, Ireland-based company posted losses of $60.9 million, or 27¢ per share, on sales of $714.7 million for the three months ended June 30, seeing losses shrink 95.6% while sales shrunk 18.4% compared with the same period last year.
Read the whole story on our sister site, Drug Delivery Business News
The post Endo shares soar on Street-beating Q2 appeared first on MassDevice.
from MassDevice https://ift.tt/2vtuP6K
Cap comentari:
Publica un comentari a l'entrada